- Products & Services
- Investor Relations
- Jobs & Careers
In this area you will find our latest press information and picture material ready to download. Our news report archive is also available here of course. In addition, a separate overview informs you about the coming dates for press conferences and the shareholder meetings of Gerresheimer AG.
If you have any individual questions or wishes please click here. We look forward to direct contact with you.
Annual General Meeting of Gerresheimer AG approves dividend of EUR 0.65 per share
Gerresheimer secures new production order
Gerresheimer begins financial year 2013 with strong revenue growth
Gerresheimer records strong revenue growth in the 2012 financial year
Gerresheimer acquires Indian pharma plastic packaging manufacturer Triveni
Rainer Beaujean has been appointed as the new Chief Financial Officer of Gerresheimer AG
Gerresheimer firmly on growth track
After a good second quarter Gerresheimer raises its revenue forecast again
We cannot prevent diseases, but our products do provide people with a better quality of life. Whatever their diagnosis, we want the people who are afflicted by these diseases to enjoy as few constraints on their mobility as possible. For example, we team up with our customers in projects to develop special inhaler and insulin pen systems for time and location-independent drug delivery.
The development of products and processes that are precisely tailored to specific applications is one of our strengths. We want our medication dosage systems to deliver maximum benefits to the user by always being fast enough.
One square millimeter is enough to make pharmaceuticals safer. We have the capability, as leading supplier, to put a unique ID on glass syringes and other primary packaging using laser coding.
Laser coding is an innovative track and trace solution for glass primary packaging. It provides the global pharmaceuticals market and patients with a standard-setting method for the reliable identification of pharmaceutical packaging.
Gerresheimer products are distinctly more perfect than their natural counterparts. Our highly specialized packaging systems and drug delivery systems facilitate the reliable, precise and convenient application of medications and provide benefits to both our customers and consumers.
Our state-of-the-art production and control technology guarantees maximum precision and quality at all times. At the German competence center in Bünde, for example, our new Pharma-Plus production line forms borosilicate glass tubing into PharmaPlus syringes in a unique combination of highly-developed and patented processes. The resulting products satisfy the very highest requirements of the pharmaceutical and biotech industry.
The world population is growing continuously and, at the same time, life expectancy is increasing. This demographic development is associated with a continuous increase in demand for medical care in addition to greater requirements of intelligent and user-friendly packaging as a result of the higher number of people suffering from chronic diseases. Gerresheimer has firm roots in the expanding global pharmaceuticals world. New medications and more convenient forms of application will continue to drive progress as the basis for further innovations and long-term growth.